Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation - Han,S.H.; Martin,P.; Edelstein,M. (Liver Transpl, 2003)